International Medical & Health Exhibition - 伦敦

The International Medical & Health Exhibition - London will grandly open on March 17, 2026, in London, UK. This exhibition focuses on the cutting-edge developments in the global medical and health field, particularly advanced therapies, an innovative hot spot. It is dedicated to creating an international platform that integrates product display, technology exchange, and business negotiation. The exhibition brings together medical device manufacturers, pharmaceutical companies, biotechnology firms, research institutions, healthcare service providers, and professionals from related fields worldwide. As a major event in the European and global medical and health industry, the London International Advanced Therapies Exhibition not only provides an excellent opportunity for exhibiting companies to deeply expand into the United Kingdom market and understand the latest trends in the Medical & Health industry but also offers a valuable platform for professional visitors to gain insights into the industry's future and seek business opportunities. The exhibition is expected to attract over 500 internationally renowned companies and welcome more than 20,000 professional visitors, including procurement representatives from medical institutions, R&D engineers, clinicians, industry investors, and policymakers. During the exhibition, multiple high-level academic seminars, technical forums, and business matching events will also be held to deeply discuss the latest advancements and application prospects of advanced therapies in oncology, neurodegenerative diseases, rare diseases, and other fields, jointly promoting innovation and development in the global medical and health industry. With its international vision, professional organization, and broad influence, the exhibition has become an indispensable annual event in the medical and health field, holding profound significance for promoting industry exchange and cooperation.

The International Medical & Health Exhibition - London features a wide range of exhibits, comprehensively covering the entire value chain of cell and gene therapy. Key exhibition areas include gene-modified cell therapies, with a focus on autologous and allogeneic cell therapies, innovative treatment solutions for solid tumors, cutting-edge technologies such as CAR-T, NK cells, and Gamma-Delta cells, and discussions on the latest applications of patient stratification and precision medicine. The cell therapy section focuses on stem cell technologies, breakthroughs in regenerative medicine, comparative studies of mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs), and the latest advancements in umbilical cord blood applications. The gene therapy exhibition area will present next-generation gene therapy technologies, discussing how to expand therapeutic applications from rare diseases to more common conditions, address immunogenicity challenges, and showcase novel gene delivery systems and gene editing tools. In addition, the exhibition also covers the manufacturing of cell therapies and viral vectors, including automation and closed systems, scale-up strategies for commercialization, cost control, and considerations for outsourced production. Supply chain and logistics are also key components, involving cold chain transportation, seamless transition from clinical to commercial, and just-in-time diagnostic delivery models. Finally, the exhibition will explore evidence, pricing, and market access strategies, as well as the latest academic research and disruptive technological innovations.

No fee information available. Please contact us for a quote.